In chronic lymphocytic leukemia (CLL), Nrf2 activation can enhance the expression of DNA repair genes such as XRCC1 and POLB, which may contribute to disease progression and resistance to chemotherapy. The gene discussed is POLB; the disease is B-cell chronic lymphocytic leukemia.